glp-1 colorectal cancer death risk study november 2025 GLP-1s in Oncology: Exploring Risks and Potential Benefits Ozempic, Wegovy might lower colon GLP-1 receptor agonists and cancer:

Your skins main job is to be a barrier - to keep things out

Why do I feel tired on GLP-1 medication

Here are some stats: Pancreatitis is seen in about 0.2% of people in studies, which is similar to people not taking the drug, but its still a known risk so its taken seriously

GLP-1s do not replace movement, nutrition, strength training, or sleep

A great example of the innovation driven by members of the Eurobiomed community and the SKIN Excellence initiative, which brings together researchers, clinicians and industry to accelerate innovation in skin health

GLP-1 receptor agonist drugs are specifically engineered to mimic the activity of the natural GLP-1 hormone and provide sustained activation of GLP-1 receptors